OTTAWA (Reuters) – Canada has approved Pfizer Inc’s COVID-19 oral antiviral treatment, the Canadian Broadcasting Corp said on Monday, citing sources, and said an announcement could be made later in the day.
Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.
(Reporting by David Ljunggren)
